Scolaris Content Display Scolaris Content Display

心血管系疾患の一次予防に対する「地中海様式」の食事について

Esta versión no es la más reciente

Contraer todo Desplegar todo

Referencias

Abedi 2010 {published data only}

Abedi P, Lee MHS, Kandiah M, Yassin Z, Shojaeezade D, Hosseini M, et al. Diet intervention to improve cardiovascular risk factors among Iranian postmenopausal women. Nutrition Research and Practice 2010;4(6):522‐7.

Castagnetta 2002 {published data only}

Carruba G, Granata OM, Pala V, Campisi I, Agostara B, Cusimano R, et al. A traditional Mediterranean diet decreases endogenous estrogens in healthy postmenopausal women. Nutrition and Cancer 2006;56(2):253‐9.
Castagnetta L, Granata OM, Cusimano R, Ravazzolo B, Liquori M, Polito L, et al. The Mediet Project. Annals of the New York Academy of Sciences 2002;963:282‐9.

Djuric 2009 {published data only}

Djuric Z, Ren J, Blythe J, VanLoon G, Sen AA. Mediterranean dietary intervention in healthy American women changes plasma carotenoids and fatty acids in distinct clusters. Nutrition Research 2009;29(3):156‐63.
Djuric Z, Vanloon G, Radakovich K, Dilaura NM, Heilbrun LK, Sen A. Design of a Mediterranean exchange list diet implemented by telephone counseling. Journal of the American Dietetic Association 2008;108(12):2059‐65.

ENCORE {published data only}

Blumenthal JA, Babyak MA, Hinderliter A, Watkins LL, Craighead L, Lin PH, et al. Effects of the DASH diet alone and in combination with exercise and weight loss on blood pressure and cardiovascular biomarkers in men and women with high blood pressure: the ENCORE study. Archives of Internal Medicine 2010;170(2):126‐35.
Blumenthal JA, Babyak MA, Sherwood A, Craighead L, Lin PH, Johnson J, et al. Effects of the dietary approaches to stop hypertension diet alone and in combination with exercise and caloric restriction on insulin sensitivity and lipids. Hypertension 2010;55(5):1199‐205.

Esposito 2004 {published data only}

Esposito K, Marfella R, Ciotola M, Di PC, Giugliano F, Giugliano G, et al. Effect of a Mediterranean‐style diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome: a randomized trial. JAMA 2004;292(12):1440‐6.

Jula 2002 {published data only}

Jula A, Marniemi J, Huupponen R, Virtanen A, Rastas M, Ronnemaa T, et al. Effects of diet and simvastatin on serum lipids, insulin, and antioxidants in hypercholesterolemic men: a randomized controlled trial. JAMA 2002;287(5):598‐605.

Konstantinidou 2010 {published data only}

Konstantinidou V, Covas MI, Munoz‐Aguayo D, Khymenets O, de la Torre R, Saez G, et al. In vivo nutrigenomic effects of virgin olive oil polyphenols within the frame of the Mediterranean diet: a randomized controlled trial. FASEB 2010;24(7):2546‐57.

Lanza 2001 {published data only}

Lanza E, Schatzkin A, Daston C, Corle D, Freedman L, Ballard‐Barbash R, et al. Implementation of a 4‐y, high‐fibre, high‐fruit‐and‐vegetable, low‐fat dietary intervention: results of dietary changes in the Polyp Prevention Trial. American Journal of Clinical Nutrition 2001;74(3):387‐401.

Lindman 2004 {published data only}

Lindman AS, Pedersen JI, Hjerkinn EM, Arnesen H, Veierod MB, Ellingsen I, et al. The effects of long‐term diet and omega‐3 fatty acid supplementation on coagulation factor VII and serum phospholipids with special emphasis on the R353Q polymorphism of the FVII gene. Thrombosis & Haemostasis 2004;91(6):1097‐104.

Wardle 2000 {published data only}

Wardle J, Rogers P, Judd P, Taylor MA, Rapoport L, Green M, et al. Randomized trial of the effects of cholesterol‐lowering dietary treatment on psychological function. American Journal of Medicine 2000;108(7):547‐53.

WHI {published data only}

Howard BV, Van HL, Hsia J, Manson JE, Stefanick ML, Wassertheil‐Smoller S, et al. Low‐fat dietary pattern and risk of cardiovascular disease: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA 2006;295(6):655‐66.
Tinker LF, Bonds DE, Margolis KL, Manson JE, Howard BV, Larson J, et al. Low‐fat dietary pattern and risk of treated diabetes mellitus in postmenopausal women: the Women's Health Initiative randomized controlled dietary modification trial. Archives of Internal Medicine 2008;168(14):1500‐11.

References to studies excluded from this review

Azadbakht 2005 {published data only}

Azadbakht L, Mirmiran P, Esmaillzadeh A, Azizi T, Azizi F. Beneficial effects of a Dietary Approaches to Stop Hypertension eating plan on features of the metabolic syndrome. Diabetes Care 2005;28(12):2823‐31.

Barcelo 2009 {published data only}

Barceló F, Perona JS, Prades J, Funari SS, Gomez‐Gracia E, Conde M, et al. Mediterranean‐style diet effect on the structural properties of the erythrocyte cell membrane of hypertensive patients the Prevencion con Dieta Mediterranea Study. Hypertension 2009;54(5):1143‐50.

Bullo 2009 {published data only}

Bulló M, Amigó‐Correig P, Márquez‐Sandoval F, Babio N, Martínez‐González MA, Estruch R, et al. Mediterranean diet and high dietary acid load associated with mixed nuts: effect on bone metabolism in elderly subjects. Journal of the American Geriatrics Society 2009;57(10):1789‐98.

Mezzano 2003 {published data only}

Mezzano D, Leighton F. Haemostatic cardiovascular risk factors: differential effects of red wine and diet on healthy young. Pathophysiology of Haemostasis & Thrombosis 2003;33(5‐6):472‐8.

Papadaki 2008 {published data only}

Papadaki A, Scott JA. Follow‐up of a web‐based tailored intervention promoting the Mediterranean diet in Scotland. Patient Education and Counseling 2008;73(2):256‐63.

Vincent‐Baudry 2005 {published data only}

Vincent‐Baudry S, Defoort C, Gerber M, Bernard MC, Verger P, Helal O, et al. The Medi‐RIVAGE study: reduction of cardiovascular disease risk factors after a 3‐mo intervention with a Mediterranean‐type diet or a low‐fat diet. American Journal of Clinical Nutrition 2005;82(5):964‐71.

References to studies awaiting assessment

Inguaggiato 2011 {published and unpublished data}

Inguaggiato R, Cisternino A, Caruso M, Reddavide R, Guerra V, Bonfiglio C, et al. Mediterranean diet at low glycemic index in the treatment of metabolic syndrome. A randomized controlled trial. Annals of Nutrition and Metabolism 2011;58:356.

Sanders 2012 {unpublished data only}

ISRCTN92382106. The effectiveness of an integrated cardioprotective dietary intervention compared with an average UK diet in reducing cardiovascular disease risk factors in older men and women aged 40 ‐ 70 years. www.controlled‐trials.com/ISRCTN92382106 (accessed 6 August 2013).

AHA 2006

American Heart Association Nutrition Committee, Lichtenstein AH, Appel LJ, Brands M, Carnethon M, Daniels S, et al. Diet and lifestyle recommendations revision 2006: a scientific statement from the American Heart Association Nutrition Committee. Circulation 2006;114:82‐96.

Appel 1997

Appel LJ, Moore TJ, Obarzanek E, Vollmer WM, Svetkey LP, Sacks FM, et al. A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group. New England Journal of Medicine 1997;336:1117‐24.

Appel 2001

Appel LJ, Espeland MA, Easter L, Wilson AC, Folmar S, Lacy CR. Effects of reduced sodium intake on hypertension control in older individuals: results from the Trial of Non‐pharmacologic Interventions in the Elderly (TONE). Archives of Internal Medicine 2001;161:685‐93.

Appel 2006

Appel LJ, Brands MW, Daniels SR, Karanja N, Elmer PJ, Frank FM. Dietary approaches to prevent and treat hypertension: a scientific statement from the American Heart Association. Hypertension 2006;47:296‐308.

Barzi 2003

Barzi F, Woodward M, Marfisi RM, Tavazzi L, Valagussa F, Marchioli R, et al. Mediterranean diet and all‐causes mortality after myocardial infarction: results from the GISSI‐Prevenzione trial. European Journal of Clinical Nutrition 2003;57:604‐11.

Benetou 2008

Benetou V, Trichopoulou A, Orfanos P, Naska A, Lagiou P, Boffetta P, et al. Conformity to traditional Mediterranean diet and cancer incidence: the Greek EPIC cohort. British Journal of Cancer 2008;99:191‐5.

Brien 2011

Brien SE, Ronksley PE, Turner BJ, Mukamal KJ, Ghali WA. Effect of alcohol consumption on biological markers associated with risk of coronary heart disease: systematic review and meta‐analysis of interventional studies. BMJ 2011;342:d636.

Buckland 2008

Buckland G, Bach A, Serra‐Majem L. Obesity and the Mediterranean diet: a systematic review of observational and interventional studies. Obesity Review 2008;9:582‐93.

Buckland 2009

Buckland G, González CA, Agudo A, Vilardell M, Berenguer A, Amiano P, et al. Adherence to the Mediterranean diet and risk of coronary heart disease in the Spanish EPIC Cohort Study. American Journal of Epidemiology 2009;170:1518‐29.

Chrysohoou 2004

Chrysohoou C, Panagiotakos DB, Pitsavos C, Das UN, Stefanadis C. Adherence to the Mediterranean diet attenuates inflammation and coagulation process in healthy adults: the ATTICA study. Journal of the American College of Cardiology 2004;44:152‐8.

Copeland 1977

Copeland KT, Checkoway H, McMichael AJ, Holbrook RH. Bias due to misclassification in the estimation of relative risk. American Journal of Epidemiology 1977;105:488‐95.

Corrao 2000

Corrao G, Rubbiati L, Bagnardi V, Zambon A, Poikolainen K. Alcohol and coronary heart disease: a meta‐analysis. Addiction 2000;95:1505‐23.

Dai 2008

Dai J, Jones DP, Goldberg J, Ziegler TR, Bostick RM, Wilson PW, et al. Association between adherence to the Mediterranean diet and oxidative stress. American Journal of Clinical Nutrition 2008;88:1364‐70.

de Lorgeril 1994

de Lorgeril M, Renaud S, Mamelle N, Salen P, Martin JL, Monjaud I, et al. Mediterranean alpha‐linolenic acid‐rich diet in secondary prevention of coronary heart disease. Lancet 1994;343:1454‐9.

de Lorgeril 1996

de Lorgeril M, Salen P, Martin JL, Mamelle N, Monjaud I, Touboul P, et al. Effect of a Mediterranean type of diet on the rate of cardiovascular complications in patients with coronary artery disease. Insights into the cardioprotective effect of certain nutriments. Journal of the American College of Cardiology 1996;28:1103‐8.

de Lorgeril 1999

de Lorgeril M, Salen P, Martin J, Monjaud I, Delaye J, Mamelle N. Mediterranean diet, traditional risk factors and the rate of cardiovascular complications after myocardial infarction: final report of the Lyon diet heart study. Circulation 1999;99:799‐85.

Department of Health 2010

Department of Health. 5‐A‐DAY general information. webarchive.nationalarchives.gov.uk/+/www.dh.gov.uk/en/Publichealth/Healthimprovement/FiveADay/FiveADaygeneralinformation/DH_4002343 (accessed 6 August 2013).

Di Castelnuovo 2002

Di Castelnuovo A, Rotondo S, Iacoviello L, Donati MB, de Gaetano G. Meta‐analysis of wine and beer consumption in relation to vascular risk. Circulation 2002;105:2836‐44.

Di Castelnuovo 2006

Di Castelnuovo A, Costanzo S, Bagnardi V, Donati MB, Iacoviello L, de Gaetano G. Alcohol dosing and total mortality in men and women: an updated meta‐analysis of 34 prospective studies. Archives of Internal Medicine 2006;166:2437‐45.

Egger 1997

Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta‐analysis detected by a simple graphical test. British Medical Journal 1997;315:629‐34.

Estruch 2006

Estruch R, Martinez‐Gonzalez MA, Corella D, Salas‐Salvadó J, Ruiz‐Gutiérrez V, Covas MI, et al. Effects of a Mediterranean‐style diet on cardiovascular risk factors: a randomized trial. Annals of Internal Medicine 2006;145:1‐11.

Estruch 2013

Estruch R, Ros E, Salas‐Salvadó J, Covas MI, Corella D, Arós F, et al. Primary prevention of cardiovascular disease with a Mediterranean diet. New England Journal of Medicine 2013;368:1279‐90. [DOI: 10.1056/NEJMoa1200303]

Feart 2009

Féart C, Samieri C, Rondeau V, Amieva H, Portet F, Dartigues JF, et al. Adherence to a Mediterranean diet, cognitive decline, and risk of dementia. JAMA 2009;302:638‐48.

Fung 2009

Fung TT, Rexrode KM, Mantzoros CS, Manson JE, Willett WC, Hu FB. Mediterranean diet and incidence of and mortality from coronary heart disease and stroke in women. Circulation 2009;119:1093‐1100.

Helsing 1989

Helsing E, Trichopoulou A. The Mediterranean diet and food culture: a symposium. European Journal of Clinical Nutrition 1989;43 Suppl 1:1‐92.

Higgins 2011

Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration 2011. Available from www.cochrane‐handbook.org.

Kastorini 2011

Kastorini CM, Milionis HJ, Esposito K, Giugliano D, Goudevenos JA, Panagiotakos DB. The effect of Mediterranean diet on metabolic syndrome and its components: a meta‐analysis of 50 studies and 534,906 individuals. Journal of the American College of Cardiology 2011;57:1299‐313.

Keys 1986

Keys A, Menotti A, Karvonen MJ, Aravanis C, Blackburn H, Buzina R, et al. The diet and 15‐year death rate in the Seven Countries Study. American Journal of Epidemiology 1986;124:903‐15.

Knoops 2004

Knoops KT, de Groot LC, Kromhout D, Perrin AE, Moreiras‐Varela O, Menotti A, et al. Mediterranean diet, lifestyle factors, and 10‐year mortality in elderly European men and women. JAMA 2004;292:1433‐9.

Krauss 2000

Krauss RM, Eckel RH, Howard B, Appel LJ, Daniels SR, Deckelbaum RJ, et al. AHA dietary guidelines: revision 2000: a statement for healthcare professionals from the Nutrition Committee of the American Heart Association. Circulation 2000;102:2284‐99.

Lagiou 2006

Lagiou P, Trichopoulos D, Sandin S, Lagiou A, Mucci L, Wolk A, et al. Mediterranean dietary pattern and mortality among young women: a cohort study in Sweden. British Journal of Nutrition 2006;96:384‐92.

Lefebvre 2011

Lefebvre C, Manheimer E, Glanville J. Chapter 6: Searching for studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org.

Martnez‐Gonzalez 2008

Martínez‐González MA, de la Fuente‐Arrillaga C, Nunez‐Cordoba JM, Basterra‐Gortari FJ, Beunza JJ, Vazquez Z, et al. Adherence to Mediterranean diet and risk of developing diabetes: prospective cohort study. BMJ 2008;336:1348‐51.

Mathers 2006

Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Medicine 2006;3(11):e442.

Mitrou 2007

Mitrou PN, Kipnis V, Thiébaut AC, Reedy J, Subar AF, Wirfält E, et al. Mediterranean dietary pattern and prediction of all‐cause mortality in a US population. Archives of Internal Medicine 2007;167:2461‐8.

Mosca 2011

Mosca L, Barrett‐Connor E, Wenger NK. Sex/gender differences in cardiovascular disease prevention: what a difference a decade makes. Circulation 2011;124:2145‐54.

Müller‐Nordhorn 2008

Müller‐Nordhorn J, Binting S, Roll S, Willich S. An update on regional variation in cardiovascular mortality within Europe. European Heart Journal 2008;29:1316‐26.

Nestle 1995

Nestle E. Mediterranean diets: science and policy implications. American Journal of Clinical Nutrition 1995;61 Suppl 6:1313‐427.

Nordmann 2011

Nordmann AJ, Suter‐Zimmermann K, Bucher HC, Shai I, Tuttle KR, Estruch R, et al. Meta‐analysis comparing Mediterranean to low‐fat diets for modification of cardiovascular risk factors. American Journal of Medicine 2011;124:841‐51.

Nunez‐Cordoba 2009

Nunez‐Cordoba JM, Valencia‐Serrano F, Toledo E, Alfonso A, Martinez‐Gonzalez MA. The Mediterranean diet and incidence of hypertension: the Seguimiento Universidad de Navarra (SUN) Study. American Journal of Epidemiology 2009;169:339‐46.

Pitsavos 2005

Pitsavos C, Panagiotakos DB, Tzima N, Chrysohoou C, Economou M, Zampelas A, et al. Adherence to the Mediterranean diet is associated with total antioxidant capacity in healthy adults: the ATTICA study. American Journal of Clinical Nutrition 2005;82:694‐9.

Psaltopoulou 2004

Psaltopoulou T, Naska A, Orfanos P, Trichopoulos D, Mountokalakis T, Trichopoulou A. Olive oil, the Mediterranean diet, and arterial blood pressure: the Greek European Prospective Investigation into Cancer and Nutrition (EPIC) study. American Journal of Clinical Nutrition 2004;80:1012‐8.

Reddy 1998

Reddy KS, Yusuf S. Emerging epidemic of cardiovascular disease in developing countries. Circulation 1998;97:596‐601.

Ronksley 2011

Ronksley PE, Brien SE, Turner BJ, Mukamal KJ, Ghali WA. Association of alcohol consumption with selected cardiovascular disease outcomes: a systematic review and meta‐analysis. BMJ 2011;342:d671.

Rumawas 2009

Rumawas ME, Meigs JB, Dwyer JT, McKeown NM, Jacques PF. Mediterranean‐style dietary pattern, reduced risk of metabolic syndrome traits, and incidence in the Framingham Offspring Cohort. American Journal of Clinical Nutrition 2009;90:1608‐14.

Ryan 2000

Ryan M, McInerney D, Owens D, Collins P, Johnson A, Tomkin GH. Diabetes and the Mediterranean diet: a beneficial effect of oleic acid on insulin sensitivity, adipocyte glucose transport and endothelium‐dependent vasoreactivity. QJM 2000;93:85‐91.

Serra‐Majem 1993

Serra‐Majem L, Helsing E. Changing patterns of fat intake in Mediterranean countries. European Journal of Clinical Nutrition 1993;47 Suppl 1:1‐100.

Serra‐Majem 2006

Serra‐Majem L, Roman B, Estruch R. Scientific evidence of interventions using the Mediterranean diet: a systematic review. Nutrition Review 2006;64:S27‐47.

Sofi 2008

Sofi F, Cesari F, Abbate R, Gensini GF, Casini A. Adherence to Mediterranean diet and health status: meta‐analysis. BMJ 2008;337:a1344.

Sofi 2010

Sofi F, Cesari F, Abbate R, Gensini GF, Casini A. Accruing evidence on benefits of adherence to the Mediterranean diet on health: an updated systematic review and meta‐analysis. American Journal of Clinical Nutrition 2010;92:1189‐96.

Stranges 2004

Stranges S, Wu T, Dorn JM, Freudenheim JL, Muti P, Farinaro E, et al. Relationship of alcohol drinking pattern to risk of hypertension: a population‐based study. Hypertension 2004;44:813‐9.

Sánchez‐Taínta 2008

Sánchez‐Taínta A, Estruch R, Bulló M, Corella D, Gómez‐Gracia E, Fiol M, et al. Adherence to a Mediterranean‐type diet and reduced prevalence of clustered cardiovascular risk factors in a cohort of 3,204 high‐risk patients. European Journal of Cardiovascular Prevention and Rehabilitation 2008;15:589‐93.

Taylor 2009

Taylor B, Irving HM, Baliunas D, Roerecke M, Patra J, Mohapatra S, et al. Alcohol and hypertension: gender differences in dose‐response relationships determined through systematic review and meta‐analysis. Addiction 2009;104:1981‐90.

Trichopoulou 1995

Trichopoulou A, Kouris‐Blazos A, Wahlqvist ML, Gnardellis C, Lagiou P, Polychronopoulos E, et al. Diet and overall survival in elderly people. BMJ 1995;311:1457‐60.

Trichopoulou 1997

Trichopoulou A, Lagiou P. Healthy traditional Mediterranean diet: an expression of culture, history, and lifestyle. Nutrition Review 1997;55:383‐9.

Trichopoulou 2003

Trichopoulou A, Costacou T, Bamia C, Trichopoulos D. Adherence to a Mediterranean diet and survival in a Greek population. New England Journal of Medicine 2003;348:2599‐608.

Trichopoulou 2007

Trichopoulou A, Bamia C, Norat T, Overvad K, Schmidt EB, Tjønneland A, et al. Modified Mediterranean diet and survival after myocardial infarction: the EPIC‐Elderly Study. European Journal of Epidemiology 2007;22:871‐81.

WHO 2003

World Health Organization Study Group. Diet, nutrition and the prevention of chronic diseases. WHO Technical Report Series 916. Geneva: WHO, 2003.

WHO 2011a

World Health Organization. Cardiovascular diseases (CVDs). Fact Sheet Number 317September 2011.

WHO 2011b

World Health Organization. Global status report on noncommunicable diseases 2010. www.who.int/nmh/publications/ncd_report2010/en/ (accessed 6 August 2013).

Willett 1995

Willett WC, Sacks F, Trichopoulou A, Drescher G, Ferro‐Luzzi A, Helsing E, et al. Mediterranean diet pyramid: a cultural model for healthy eating. American Journal of Clinical Nutrition 1995;61 Suppl 6:1402‐6.

Characteristics of studies

Characteristics of included studies [ordered by study ID]

Abedi 2010

Methods

RCT of parallel group design.

Participants

Postmenopausal women recruited from a health clinic in Iran.

Inclusion criteria: women had at least primary education, were postmenopausal (no menstruation for at least 12 months) and CVD free (by self report).

76 women randomised, 38 in the intervention group (mean age (SD) 51.4 years (4.9)), and 38 to the control group (mean age 51.6 years (5.7)).

Interventions

Dietary education to increase consumption of fruits and vegetables and whole grains, to eat fish twice a week and limit saturated fat and salt. The intervention comprised 5 educational sessions (2 face‐to‐face and 3 lecture discussion classes with slide demonstrations) in the first month, a further face‐to‐face session at month 3 and telephone calls each month to remind women to remain on the diet. Information was also provided about CVD and the menopause as well as diet. The intervention period was 6 months, with follow‐up at 6 months. The comparison group received no intervention.

Outcomes

Total cholesterol, LDL‐cholesterol, HDL‐cholesterol, triglycerides, SBP and DBP.

Notes

Differential loss to follow‐up in the control group of greater than 20% so sensitivity analyses were performed to examine the effect of excluding this study on the overall effect estimates for lipid levels and blood pressure.

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Unclear risk

Not stated.

Allocation concealment (selection bias)

Unclear risk

Not stated.

Blinding of participants and personnel (performance bias)
All outcomes

Unclear risk

Not stated.

Blinding of outcome assessment (detection bias)
All outcomes

Unclear risk

Not stated.

Incomplete outcome data (attrition bias)
All outcomes

High risk

Differential loss to follow‐up of 7.9% in the intervention group compared with 23.7% in the control group. Participants in the intervention group did not attend education sessions, reasons were not given for losses to follow‐up in the control group.

Selective reporting (reporting bias)

Low risk

Report all outcomes as stated.

Other bias

Unclear risk

Insufficient information to judge.

Castagnetta 2002

Methods

RCT of parallel group design.

Participants

Healthy postmenopausal female volunteers aged 44‐71 years recruited by press campaign from Palermo (Southern Italy).

Inclusion criteria: postmenopausal for at least 2 years, no history of bilateral ovariectomy, no HRT within the previous year, no history of cancer, no adherence to a vegetarian or macrobiotic diet, no treatment for diabetes, thyroid disease or chronic bowel disease.

230 fulfilled these eligibility criteria and 115 women were enrolled in the study based on serum testosterone levels equal to or greater than the median population level (0.14 μg/mL). 58 women were randomised to the intervention group, 55 women to the control group.

Interventions

MEDIET project ‐ the intervention group were invited to a weekly cooking course and to a social dinner with chefs addressing the principles of the traditional Mediterranean diet. The proposed recipes were based on a traditional Sicilian diet including whole cereals, legumes, seeds, fish, fruits, vegetables, olive oil and red wine. Women were asked to avoid refined carbohydrates, salt and additional animal fat. The intervention ran for 6 months from January to June 2000, then from 3 months from October to December 2000. Women were instructed to consume the same foods on a daily basis at home. The comparison group followed their usual diet. The follow‐up period was at 6 and 12 months.

Outcomes

Plasma cholesterol.

Notes

The primary publication (Castagnetta 2002) stated that the comparison group was advised to increase the consumption of fruits and vegetables as recommended by the WHO. However, other reports of the study stated that women in the control group followed their usual diets (Carruba 2006, secondary reference for this study).

No data were provided on cholesterol levels in the paper but simply a statement that they had reduced. We have contacted the authors several times to request the data to include in our analyses but, unfortunately, to date this has not been forthcoming.

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Unclear risk

Block randomisation stratified for baseline parameters.

Allocation concealment (selection bias)

Unclear risk

Not stated.

Blinding of participants and personnel (performance bias)
All outcomes

Unclear risk

Not stated.

Blinding of outcome assessment (detection bias)
All outcomes

Unclear risk

Not stated.

Incomplete outcome data (attrition bias)
All outcomes

Unclear risk

No ITT analysis, < 20% loss to follow‐up in both groups but no reasons provided.

Selective reporting (reporting bias)

Unclear risk

Insufficient information to judge.

Other bias

Unclear risk

Insufficient information to judge.

Djuric 2009

Methods

RCT of parallel group design.

Participants

Healthy non‐obese women aged 25‐65 years recruited from adverts in community newsletters, health fairs, flyers and employee newsletters in Michigan, US. Women completed 7‐day food diaries.

Eligibility criteria: fat intake was at least 23% of calories with no more than 48% from MUFA and fruit and vegetable intake was < 5.5 servings per day. This was to reflect a typical American intake. Women had to have good general health, be current non‐smokers and be in the normal to overweight range (BMI 18‐30).

Exclusion criteria: chronic diseases such as diabetes, autoimmune disease, hypertension, being on medically prescribed diets, taking dietary supplements > 150% RDA, pregnant or lactating and being treated with therapies or supplements that could obscure the results. 69 women were randomised, mean age 44 years (range 25‐59) and mean BMI 24 (19‐30).

Interventions

The intervention was a Greek Mediterranean exchange list diet with exchange goals determined by dieticians at baseline and focused on increasing fruit and vegetable intake and variety and increasing MUFA intake while maintaining the baseline energy intake and total fat intake. The fruit and vegetable goal was 7‐9 servings/day depending on baseline calorie intake and maintaining baseline energy intake was achieved by substituting fruit and vegetables for other carbohydrates. Variety was achieved using exchange lists. The fat intake goal was PUFA:SFA:MUFA ratio of 1:2:5. This was achieved by reducing usual fat intakes by half using low‐fat food and then adding in olive oil or other high MUFA to the diet to keep energy and total fat intake at baseline levels. Participants were given 3 L of extra‐virgin olive oil at baseline and at 3 months. 7‐day food records were taken at baseline, 3 months and 6 months. Counselling by the dieticians occurred weekly by telephone for the first 3 months and twice weekly thereafter. Face‐to‐face counselling occurred at baseline and 3 months. The intervention period was 6 months. Women were counselled on home eating patterns, restaurant eating, eating at work and special occasions.

The comparison group followed their usual diets. They did not receive counselling, but were given the National Cancer Institutes Action guide to healthy eating and written materials on nutritional deficiencies if below 67% RDA. Follow‐up was at 6 months after the end of the intervention period.

Outcomes

Total cholesterol, LDL‐cholesterol, HDL‐cholesterol and triacylglycerol.

Notes

Differential loss to follow‐up in the intervention group of > 20% so sensitivity analyses were performed to examine the effect of excluding this study on the overall effect estimates for lipid levels.

Body weight increased by 0.24 kg in the control group and decreased by 1.21 kg in the intervention group after the 6‐month intervention period.

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Unclear risk

Method not stated. Subjects stratified by race and menopausal status prior to randomisation using a block design of 6.

Allocation concealment (selection bias)

Unclear risk

Not stated.

Blinding of participants and personnel (performance bias)
All outcomes

Unclear risk

Not stated.

Blinding of outcome assessment (detection bias)
All outcomes

Unclear risk

Not stated.

Incomplete outcome data (attrition bias)
All outcomes

High risk

Differential loss to follow‐up of 23% in the intervention group compared with 3% in the control group. No reasons for loss to follow‐up reported.

Selective reporting (reporting bias)

Low risk

Report all outcomes as stated.

Other bias

Unclear risk

Insufficient information to judge.

ENCORE

Methods

RCT of parallel group design.

Participants

Participants were overweight or obese with untreated hypertension (SBP 130‐159 mmHg, DBP 85‐99 mmHg based on 4 screening visits) recruited from physician referrals, community screenings, mass media advertising in North Carolina, US. 144 participants randomised (46 to DASH alone, 49 to control), mean age was 52 years and 32.6% were men.

Interventions

The DASH diet:

  • was low in saturated fat, cholesterol and total fat;

  • focused on fruits, vegetables, and fat‐free or low‐fat dairy products;

  • was rich in whole grains, fish, poultry, beans, seeds and nuts;

  • contained fewer sweets, added sugars and sugary beverages, and red meats than the typical American diet.

Participants in the intervention group received counselling on the DASH diet and provided feedback on their adherence in weekly group sessions. The goal of the sessions was to assist participants in learning how to buy and prepare appropriate foods, enhance their motivation to choose to eat these foods and to overcome any obstacles. A nutritionalist made the recommendations and small group sessions were held weekly (30‐45 minutes each) at the research centre. Immediately after randomisation and before the counselling sessions participants entered a 2‐week controlled isocalorific feeding period to improve compliance with the DASH diet. The comparison group were asked to maintain their usual dietary and exercise habits. Follow‐up was at 4 months after the intervention period.

Outcomes

Total, HDL‐cholesterol, LDL‐cholesterol, triglycerides, SBP, DBP.

Notes

2 intervention groups ‐ DASH alone and DASH plus weight management. The review looked at only at the DASH alone arm.

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Low risk

Randomised in groups of 2‐5 participants using a computer program.

Allocation concealment (selection bias)

Low risk

Sealed envelopes used so allocation was concealed.

Blinding of participants and personnel (performance bias)
All outcomes

Unclear risk

Participants were provided their treatment group assignments in sealed envelopes, which suggests they were unblinded. However, blinding of participants and personnel for behavioural interventions is difficult and often not possible so we have not judged this as at high risk of bias.

Blinding of outcome assessment (detection bias)
All outcomes

Low risk

Staff members performing the assessments were unaware of group assignment.

Incomplete outcome data (attrition bias)
All outcomes

Low risk

Only 1 participant lost to follow‐up and ITT analysis used.

Selective reporting (reporting bias)

Low risk

All expected outcomes reported.

Other bias

Unclear risk

Insufficient information to judge.

Esposito 2004

Methods

RCT of parallel group design.

Participants

Men and women were recruited from June 2001 to January 2004 among those attending the outpatient department of the Division of Metabolic Diseases at the Second University of Naples, Naples, Italy. 180 adults (99 men and 81 women), mean age 44.3 years (intervention diet) and 43.5 years (control diet) with metabolic syndrome were enrolled in the study.

Inclusion criteria: ≥ 3 of the following: (1) abdominal adiposity (defined as waist circumference 102 cm (men) or 88 cm (women)); (2) low levels of serum HDL‐cholesterol (40 mg/dL (men) or 50 mg/dL (women)); (3) hypertriglyceridaemia (triglycerides level of ≥ 150 mg/dL); (4) elevated blood pressure (≥ 130/85 mmHg); and (5) impaired glucose homeostasis (fasting plasma glucose concentration ≥ 110 mg/dL).

Exclusion criteria: CVD, psychiatric problems, a history of alcohol abuse (alcohol consumption 500 g/week in the last year), if they smoked, or if they took any medication.

Interventions

Intervention diet: 90 participants were given detailed advice about the usefulness of a Mediterranean‐style diet. Through a series of monthly small‐group sessions, participants received education in reducing dietary calories (if needed), personal goal‐setting and self monitoring using food diaries. Behavioural and psychological counselling was also offered. Dietary advice was tailored to each participant on the basis of 3‐day food records. The recommended composition of the dietary regimen was carbohydrates, 50‐60%; proteins, 15‐20%; total fat, < 30%; saturated fat, < 10%; and cholesterol consumption, < 300 mg/day. Participants were advised to consume at least 250‐300 g of fruits, 125‐150 g of vegetables, 25‐50 g of walnuts, 400 g of whole grains (legumes, rice, maize and wheat) daily and to increase their consumption of olive oil. Participants were in the programme for 24 months and had monthly sessions with the nutritionist for the first year and twice monthly sessions for the second year. Compliance with the programme was assessed by attendance at the meetings and completion of diet diaries.

Control diet: 90 participants were given general oral and written information about healthy food choices at baseline and at subsequent visits. The general recommendation for macro‐nutrient composition of the diet was similar to that for the intervention group (carbohydrates, 50‐60%; proteins, 15‐20% and total fat, 30%). Participants had bimonthly sessions with study personnel.

Participants in both groups also received guidance on increasing their level of physical activity, mainly by walking for a minimum of 30 minutes/day but also by swimming or playing aerobic ball games.

Trial was conducted from June 2001 to January 2004. Follow‐up period was 2 years.

Outcomes

Total cholesterol, HDL‐cholesterol, triglycerides, SBP, SBP.

Notes

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Low risk

Computer‐generated random number sequence.

Allocation concealment (selection bias)

Low risk

Stored in sealed study folders and held in a central, secured location until informed consent obtained.

Blinding of participants and personnel (performance bias)
All outcomes

Unclear risk

Staff members involved in the intervention had to be aware of the group assignment; thus, the study was only partly blinded. Blinding of participants and personnel for behavioural interventions is difficult and often not possible, so we have not judged this as at high risk of bias.

Blinding of outcome assessment (detection bias)
All outcomes

Low risk

Laboratory staff did not know to which group the participants were assigned.

Incomplete outcome data (attrition bias)
All outcomes

Low risk

ITT analysis.

Selective reporting (reporting bias)

Low risk

All expected outcomes reported.

Other bias

Unclear risk

Insufficient information to judge.

Jula 2002

Methods

RCT cross‐over design (analysed as a parallel group, 12‐week intervention, 12‐week follow‐up).

Participants

Hypercholesterolaemic men, 35‐64 years of age were screened from the clients of the occupational health service of 5 industrial plants and government offices in Turku in southwestern Finland. 120 men were enrolled.

Inclusion criteria: a fasting serum cholesterol concentration 232‐309 mg/dL (6.0‐8.0 mmol/L) and fasting serum triglyceride concentration no higher than 266 mg/dL (3.0 mmol/L).

Exclusion criteria: BMI > 32 kg/m2; coronary artery disease; cerebrovascular disease; claudication and pharmacologically treated hypertension, hyperlipidaemia, or diabetes.

Interventions

Men included in the study entered first a 4‐ to 6‐week open placebo run‐in period, at the end of which they were randomly allocated to the intervention (60 men, mean age 48.0 years) or control group (60 men, mean age 48.4 years).

The intervention (a weight stable, modified, Mediterranean‐type diet) consisted of no more than 10% energy from SFAa and transunsaturated fatty acids; cholesterol intake no more than 250 mg/day; omega‐3 fatty acid intake of plant origin (linolenic acid) and marine origin of at least 4 g/day and the ratio of omega‐6/omega‐3 PUFAs < 4; and increased intakes of fruits, vegetables and soluble fibre. Men were advised to use leaner meat products, low‐fat cheese, skimmed milk, fat‐free sour milk and low‐fat yogurt. Fish was recommended as a main meal once or twice a week. Rapeseed margarine was recommended as a replacement for butter, a mixture of butter and vegetable oils, and sunflower margarine. Rapeseed margarine and oil, oat bran (20 g/day), and frozen berries (blueberry, lingonberry or blackcurrant at 50 g/day) were supplied free to study subjects. The diet was supervised by a nutritionist in 1 individual session and in 2 group counselling sessions at the beginning of the treatment and in 5 subsequent monthly group brush‐up sessions during the dietary treatment. The control group participants (habitual diet group) were advised to continue eating their usual diet during the study period.

The trial was conducted between August 1997 and June 1998.

Outcomes

Total cholesterol, HDL‐cholesterol, LDL‐cholesterol, triglycerides.

Notes

Data were only used for the first 12 weeks of the trial (before the second randomisation and subsequent cross‐over). Follow‐up data (mean and SD) for each of the outcomes was missing. Authors were contacted 3 times for follow‐up data for all outcomes but with no success.

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Unclear risk

Not stated.

Allocation concealment (selection bias)

Unclear risk

Not stated.

Blinding of participants and personnel (performance bias)
All outcomes

Unclear risk

Dietary treatment was performed single‐blind. Blinding of participants and personnel for behavioural interventions is difficult and often not possible so we have not judged this as at high risk of bias.

Blinding of outcome assessment (detection bias)
All outcomes

Low risk

All measurements and analyses were done blinded to the treatment allocation of the subject.

Incomplete outcome data (attrition bias)
All outcomes

High risk

No reason given for attrition.

Selective reporting (reporting bias)

Unclear risk

Blood pressure not reported.

Other bias

Unclear risk

Insufficient information to judge.

Konstantinidou 2010

Methods

RCT of parallel group design.

Participants

From October 2007 to October 2008, 90 eligible community‐dwelling adults (26 men and 64 women, aged 20‐50 years) were recruited from primary care centres. They were considered healthy on the basis of a physical examination and routine biochemical and haematological laboratory determinations.

Exclusion criteria: intake of antioxidant supplements; intake of acetosalicylic acid or any other drug with established antioxidative properties; high levels of physical activity (3000 kcal/week in leisure‐time physical activity); obesity (BMI 30 kg/m2); hypercholesterolaemia (total cholesterol 8.0 mM or dyslipidaemia therapy); diabetes (glucose 126 mg/dL or diabetes treatment); hypertension (SBP ≥ 140 mmHg) or (DBP ≥ 90 mmHg), or both or antihypertensive treatment; multiple allergies; coeliac or other intestinal diseases; any condition that could limit the mobility of the subject, making study visits impossible; life‐threatening illnesses or other diseases or conditions that could worsen adherence to the measurements or treatments; vegetarianism or a need for other special diets; and alcoholism or other drug addiction.

Interventions

Participants were assigned to 1 of 2 interventions or a control group as follows:

1. Traditional Mediterranean diet with virgin olive oil (30 participants);

2. Traditional Mediterranean diet with washed virgin olive oil (30 participants).

The dietician gave personalised advice during a 30‐minute session to each participant following the traditional Mediterranean diets, with recommendations on the desired frequency of intake of specific foods. Participants were instructed to use olive oil for cooking and dressing; increase consumption of fruit, vegetables and fish; consume white meat instead of red or processed meat; prepare homemade sauce with tomato, garlic, onion, aromatic herbs and olive oil to dress vegetables, pasta, rice, and other dishes; and, for alcohol drinkers, moderate consumption of red wine.

3. Control group (30 subjects): participants were advised by a dietician to maintain their habitual lifestyle.

Intervention period and follow‐up was 3 months.

Outcomes

Total cholesterol, HDL‐cholesterol, LDL‐cholesterol, triglycerides, SBP, DBP.

Notes

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Low risk

Computer generated random number sequence.

Allocation concealment (selection bias)

Unclear risk

Not stated.

Blinding of participants and personnel (performance bias)
All outcomes

Unclear risk

Not stated.

Blinding of outcome assessment (detection bias)
All outcomes

Unclear risk

Not stated.

Incomplete outcome data (attrition bias)
All outcomes

Low risk

Only 1 participant dropped out of the trial.

Selective reporting (reporting bias)

Unclear risk

Not stated.

Other bias

Unclear risk

Not stated.

Lanza 2001

Methods

RCT of parallel group design.

Participants

The Polyp Prevention Trial ‐ a multicentre trial (8 US clinical centres) to examine the effect of diet on recurrence of adenomatous polyps in the large bowel. Participants were at high risk with ≥ 1 colorectal adenomas removed within 6 months before recruitment. Referrals were from endoscopists and recruitment took place between 1991 and 1994. 2079 participants were randomised, 64.5% men, mean age 61 years.

Interventions

Intensive counselling to follow a low‐fat (< 20% calories), high‐fibre (18 g/1000 cal) diet and to increase fruit and vegetable consumption to 3.5 servings/1000 cal. Nutritional education and behavioural modification techniques used by a registered dietician. In the first year, counselling sessions were weekly for the first 6 weeks, biweekly for the next 6 weeks and monthly thereafter. In year 2, counselling sessions were in groups every 2 months and participants were also contacted by telephone at least once a month. In years 3 and 4, counselling sessions were held quarterly in groups. More than 50 hours of counselling sessions over 4 years. Comparison group were given a standard brochure on healthy eating. Follow‐up at 4 years.

Outcomes

Plasma cholesterol in mmoles/litre

Notes

Plasma cholesterol only measured in a subgroup of participants, n = 370 and n = 374 for the intervention and control groups, respectively.

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Unclear risk

Not stated.

Allocation concealment (selection bias)

Unclear risk

Not stated.

Blinding of participants and personnel (performance bias)
All outcomes

Unclear risk

Not stated.

Blinding of outcome assessment (detection bias)
All outcomes

Unclear risk

Not stated.

Incomplete outcome data (attrition bias)
All outcomes

Low risk

ITT analysis used and loses to follow‐up reported.

Selective reporting (reporting bias)

Low risk

All outcomes stated are reported.

Other bias

Unclear risk

Insufficient information to judge.

Lindman 2004

Methods

RCT of parallel group design (2 x 2 factorial design).

Participants

219 older men with long‐standing hypercholesterolaemia were recruited from the Diet and Omega‐3 Intervention trial on atherosclerosis (DOIT) study, Norway. Mean age 69.7 years for both genotypes.

Interventions

Men were randomised into 3 intervention groups or the control group as follows:

  • usual care and placebo capsules (control group) (n = 51);

  • dietary advice ('Mediterranean‐type' diet) and placebo capsules (n = 47);

  • usual care and VLC n‐3 capsules (n = 51);

  • dietary advice ('Mediterranean‐type' diet) and VLC n‐3 capsules (n = 52).

Diet counselling was given individually by a clinical nutritionist based on a food frequency questionnaire. The food frequency questionnaire was also answered by the participants at the end of the main study (36 months). Energy content and nutrient composition was of the diet were calculated from the questionnaires at baseline and 36 months. Dietary advice was given during 30‐45 minutes at time of randomisation, and for 30 minutes after 3 months. Participants were supported with a margarine rich in PUFA and vegetable oils free of cost. Advice was given to increase intake of vegetables, fruit and fish, and decrease consumption of meat and target energy percents at 27‐30% fat, 15‐18% protein and 50‐55% carbohydrate. To fulfil these goals participants were recommended to use rapeseed or olive oil for cooking; use leafy vegetables daily; include fruits, berries and nuts in the diet; eat fish 3 times per week; use wholemeal bread, skimmed milk and reduced‐fat cheese. 2 capsules were taken twice daily corresponding to 2.4 g VLC n‐3 capsules or 2.4 g corn oil (placebo capsules).

Follow‐up period was 6 months.

Outcomes

Triglycerides.

Notes

Only data from the usual care and placebo capsules (control group) (n = 51) and dietary advice ('Mediterranean type' diet) and placebo capsules (n = 47). (The focus of the study was to investigate the effect of long‐term diet and VLC n‐3 fatty acids intervention on plasma coagulation factor VII (FVII), choline‐containing phospholipids and triglycerides, especially relating to the R353Q polymorphism of the FVII gene).

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Unclear risk

Not stated.

Allocation concealment (selection bias)

Unclear risk

Not stated.

Blinding of participants and personnel (performance bias)
All outcomes

Unclear risk

Not stated.

Blinding of outcome assessment (detection bias)
All outcomes

Unclear risk

Not stated.

Incomplete outcome data (attrition bias)
All outcomes

Unclear risk

Insufficient reporting of attrition/exclusions.

Selective reporting (reporting bias)

Unclear risk

Insufficient information to judge.

Other bias

Unclear risk

Insufficient information to judge.

Wardle 2000

Methods

RCT of parallel group design.

Participants

Participants were adults with mild to moderate hypercholesterolaemia with serum cholesterol levels above 5.2 mmol/L, not current or previous (within 3 months) users of lipid‐lowering medication and with no serious illness. Participants were recruited from dietetic clinics, hospital physicians and general practitioners in London and the South East, UK. 117 participants were randomised, mean age 53.5 years, 43.5% men.

Interventions

The intervention (Mediterranean diet) was delivered in 8 sessions during the 12‐week intervention period using a combination of individual and group sessions with a dietician and psychologist. Dietary advice was to increase intake of fruit and vegetables, and oily fish and to reduce fat to 30% of energy with substitution of predominantly monosaturated fat for saturated fat. All participants received individualised advice to implement dietary changes based on their lifestyle and food preferences and group support in maintaining changes. Intervention participants were also given free spreading fats and oils high in monosaturated fats. The comparison group was a wait‐list control. Participants were told it was necessary to wait for treatment but that they would be seen at 6‐week intervals. They were not given any specific dietary advice but were not discouraged from making changes and some participants did so. 12 weeks' follow‐up.

Outcomes

Total cholesterol, LDL‐cholesterol, HDL‐cholesterol, triglycerides.

Notes

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Unclear risk

Not stated.

Allocation concealment (selection bias)

Low risk

Opaque sealed envelopes.

Blinding of participants and personnel (performance bias)
All outcomes

Unclear risk

No details provided but the control group was a wait‐list control.

Blinding of outcome assessment (detection bias)
All outcomes

Unclear risk

Outcome assessment done by a member of the research team who was blinded (in most cases).

Incomplete outcome data (attrition bias)
All outcomes

Low risk

No ITT but details of attrition provided and reasons.

Selective reporting (reporting bias)

Low risk

All of the outcomes stated were reported.

Other bias

Unclear risk

Insufficient information to judge.

WHI

Methods

RCT of parallel group design.

Participants

48,835 postmenopausal women aged 50‐79 years were recruited and enrolled between 1993 and 1998 at 40 clinical centres across the US.

Eligibility criteria: being postmenopausal and consuming at baseline a diet with fat intake of 32% or more of total calories, as assessed by a food frequency questionnaire.

Exclusion criteria: history of breast cancer or colorectal cancer, any cancer within the previous 10 years except non‐melanoma skin cancer, medical conditions with a predicted survival of less than 3 years, adherence or retention concerns, current dietary intake of less than 32% of energy from fat, and type 1 diabetes mellitus.

Interventions

Women were randomly assigned to a usual‐diet comparison group (n = 29,294, 60.0%) or an intervention group with a 20% low‐fat dietary pattern with increased vegetables, fruits and grains (n = 19,541, 40.0%).

The intervention was designed to promote dietary change with the goals of reducing intake of total fat to 20% of energy intake (in kilocalories) by increasing intake of vegetables and fruits to at least 5 servings daily and of grains to at least 6 servings daily. The intervention did not include total energy reduction or weight loss goals. Although not a separate focus of the intervention, it was presumed that by reducing total fat intake to 20% kcal, intake of saturated fat would also be reduced (7% energy intake). The intensive behavioural modification programme involved 18 group sessions in the first year and quarterly maintenance sessions thereafter, led by specially trained and certified nutritionists. Participants self monitored total fat‐gram intake and also servings of vegetables, fruits and grains.

Women in the comparison group received a copy of the Dietary Guidelines for Americans as well as other health‐related materials, but had no contact with the nutrition interventionists.

Mean follow‐up time for the WHI DMT was 8.1 years.

Outcomes

CVD mortality, myocardial infarction and stroke (at 8.1 years); total cholesterol, HDL‐cholesterol and LDL‐cholesterol (at year 3); triglycerides (at year 3); SBP and DBP (at years 1 and 3); type 2 diabetes (at 8.1 years).

Notes

Blood measures (total, HDL‐cholesterol, LDL‐cholesterol and triglycerides) were performed on a 5.8% subsample at year 3.

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Low risk

Used a randomised permuted block algorithm.

Allocation concealment (selection bias)

Unclear risk

Not stated.

Blinding of participants and personnel (performance bias)
All outcomes

Unclear risk

Not stated.

Blinding of outcome assessment (detection bias)
All outcomes

Low risk

Carried out by physician adjudicators not involved in trial.

Incomplete outcome data (attrition bias)
All outcomes

Low risk

ITT analysis.

Selective reporting (reporting bias)

Low risk

All outcomes reported.

Other bias

Unclear risk

Insufficient information to judge.

BMI: body mass index; CVD: cardiovascular disease; DASH: ; DBP: diastolic blood pressure; HDL: high‐density lipoprotein; HRT: hormone replacement therapy; ITT: intention to treat; LDL: low‐density lipoprotein; MUFA: monounsaturated fatty acid; PUFA: polyunsaturated fatty acid; RCT: randomised controlled trial; RDA: recommended daily allowance; SBP: systolic blood pressure; SD: standard deviation; SFA: saturated fatty acid; VLC: very‐long‐chain; WHO: World Health Organization.

Characteristics of excluded studies [ordered by study ID]

Study

Reason for exclusion

Azadbakht 2005

Not an RCT ‐ control group were a separate population.

Barcelo 2009

PREDIMED study. Low‐fat diet arm had face‐to‐face nutritional advice as well as leaflets, therefore, not a minimal control.

Bullo 2009

Substudy of PREDIMED. Control group received face‐to‐face nutritional advice, therefore, not a minimal control, and there were no relevant outcomes.

Mezzano 2003

Not all subjects were randomised.

Papadaki 2008

Not an RCT.

Vincent‐Baudry 2005

Medi‐RIVAGE study. Control group was given dietary advice to eat fruit and vegetables, therefore, not a minimal control.

RCT: randomised controlled trial.

Characteristics of studies awaiting assessment [ordered by study ID]

Inguaggiato 2011

Methods

RCT of parallel group design

Participants

219 participants with metabolic syndrome (NCEP‐ATPIII criteria).

Interventions

4 intervention groups: to follow a Mediterranean diet, a low GI Mediterranean diet, low GI diet and a generic diet (comparison group). Follow‐up after the 12‐week intervention period.

Outcomes

Lipid levels, blood pressure

Notes

Conference abstract. Contacted authors for further details of the trial and outcome data. Authors are currently trying to publish a paper and are unwilling at present to share their data with us.

GI: glycaemic index; NCEP‐ATPIII: National Cholesterol Education Program‐ Adult Treatment Panel III; RCT: randomised controlled trial.

Characteristics of ongoing studies [ordered by study ID]

Sanders 2012

Trial name or title

Cardiovascular risk REduction Study: Supported by an Integrated Dietary Approach

Methods

Randomised parallel design single‐centre controlled trial

Participants

Inclusion criteria:

  1. Healthy men and women, aged 40‐70 years

Exclusion criteria:

  1. a reported history of angina, myocardial infarction, peripheral vascular disease, congenital heart disease or stroke;

  2. Asymptomatic atrial fibrillation;

  3. type 1 or type 2 diabetes mellitus (fasting plasma glucose > 7 mmol/L);

  4. seated blood pressure > 160/105 mmHg;

  5. current use of medication for lowering blood cholesterol (statins) or blood pressure;

  6. body mass index < 18.5 and > 35 kg/m2;

  7. an overall risk of cardiovascular disease over the next 10 years of > 20% assessed according to current NICE guidelines in combination with untreated hypertension or raised cholesterol;

  8. clinical history of cancer (excluding basal cell carcinoma) in the past 5 years;

  9. chronic renal, liver or inflammatory bowel disease;

  10. current cigarette smoker (confirmed by urinary cotinine analysis);

  11. history of substance abuse or alcoholism (previous weekly alcohol intake > 60 units/men or 50 units/women);

  12. current self reported weekly alcohol intake not exceeding 21 units for women and 28 units for men;

  13. currently pregnant, planning pregnancy or having had a baby in the last 12 months;

  14. unwilling to follow the protocol or give informed consent, or both;

  15. unwilling to refrain from use of dietary supplements;

  16. unwilling to restrict consumption of oily fish;

  17. weight change of > 3 kg in preceding 2 months

Interventions

This is a controlled dietary intervention trial comparing a cardioprotective diet (decreased salt and saturated fatty acid intake, and increased whole grain cereals, fruit and vegetables and oily fish intake) with a control diet (average UK diet) for 3 months.

Outcomes

Primary outcome measures:

  1. a change in systolic blood pressure measured by ambulatory blood pressure;

  2. a change in endothelial function measured by flow‐mediated dilation;

  3. a change in total/high‐density lipoprotein (HDL) cholesterol ratio measured at baseline and 3 months.

Secondary outcome measures:

  1. a change in arterial stiffness (pulse wave velocity and digital volume pulse), measured at baseline and 3 months;

  2. a change in insulin sensitivity (revised quantitative insulin sensitivity test (RQUICKI) and serum adiponectin), measured at baseline and 3 months;

  3. a change in C‐reactive protein concentrations, measured at baseline and 3 months.

Starting date

16 July 2010

Contact information

Prof Thomas Sanders

Nutritional Science Division
4th Floor, Franklin‐Wilkins Building
150 Stamford Street

London

SE1 9NH

UK

+44 (0)20 7848 4273

+44 (0)20 7848 4171

[email protected]

Notes

Ongoing trial (ISRCTN92382106) that has been classified as 'completed' on www.controlled‐trials.com

Trial website: www.medscinet.net/CRESSIDA/

Study duration: July 2010 to December 2012

NICE: national Institute for Health and Clinical Excellence.

Data and analyses

Open in table viewer
Comparison 1. Mediterranean dietary intervention versus no intervention or minimal intervention (secondary outcomes ‐ CVD risk factors)

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Total cholesterol (mmol/L), change from baseline Show forest plot

8

4151

Mean Difference (IV, Random, 95% CI)

‐0.16 [‐0.26, ‐0.06]

Analysis 1.1

Comparison 1 Mediterranean dietary intervention versus no intervention or minimal intervention (secondary outcomes ‐ CVD risk factors), Outcome 1 Total cholesterol (mmol/L), change from baseline.

Comparison 1 Mediterranean dietary intervention versus no intervention or minimal intervention (secondary outcomes ‐ CVD risk factors), Outcome 1 Total cholesterol (mmol/L), change from baseline.

2 Total cholesterol (mmol/L), change from baseline, subgroup analysis Show forest plot

8

3815

Mean Difference (IV, Fixed, 95% CI)

‐0.20 [‐0.23, ‐0.17]

Analysis 1.2

Comparison 1 Mediterranean dietary intervention versus no intervention or minimal intervention (secondary outcomes ‐ CVD risk factors), Outcome 2 Total cholesterol (mmol/L), change from baseline, subgroup analysis.

Comparison 1 Mediterranean dietary intervention versus no intervention or minimal intervention (secondary outcomes ‐ CVD risk factors), Outcome 2 Total cholesterol (mmol/L), change from baseline, subgroup analysis.

2.1 Interventions described as Mediterranean diet (or comprise both increased fruit and vegetables and monounsaturated fatty acids)

4

436

Mean Difference (IV, Fixed, 95% CI)

‐0.23 [‐0.27, ‐0.20]

2.2 Interventions with 2 components but not described as Mediterranean diet or comprising both increased fruit and vegetables and monounsaturated fatty acids

4

3379

Mean Difference (IV, Fixed, 95% CI)

‐0.06 [‐0.13, 0.01]

3 LDL‐cholesterol (mmol/L), change from baseline Show forest plot

6

3227

Mean Difference (IV, Fixed, 95% CI)

‐0.07 [‐0.13, ‐0.01]

Analysis 1.3

Comparison 1 Mediterranean dietary intervention versus no intervention or minimal intervention (secondary outcomes ‐ CVD risk factors), Outcome 3 LDL‐cholesterol (mmol/L), change from baseline.

Comparison 1 Mediterranean dietary intervention versus no intervention or minimal intervention (secondary outcomes ‐ CVD risk factors), Outcome 3 LDL‐cholesterol (mmol/L), change from baseline.

4 LDL‐cholesterol (mmol/L), change from baseline, subgroup analysis Show forest plot

6

3227

Mean Difference (IV, Random, 95% CI)

‐0.07 [‐0.17, 0.03]

Analysis 1.4

Comparison 1 Mediterranean dietary intervention versus no intervention or minimal intervention (secondary outcomes ‐ CVD risk factors), Outcome 4 LDL‐cholesterol (mmol/L), change from baseline, subgroup analysis.

Comparison 1 Mediterranean dietary intervention versus no intervention or minimal intervention (secondary outcomes ‐ CVD risk factors), Outcome 4 LDL‐cholesterol (mmol/L), change from baseline, subgroup analysis.

4.1 Interventions described as Mediterranean diet (or comprise both increased fruit and vegetables and monounsaturated fatty acids)

3

252

Mean Difference (IV, Random, 95% CI)

‐0.16 [‐0.39, 0.07]

4.2 Interventions with 2 components but not described as the Mediterranean diet or comprising both increased F&V and MUFAs

3

2975

Mean Difference (IV, Random, 95% CI)

‐0.06 [‐0.12, 0.00]

5 HDL‐cholesterol (mmol/L), change from baseline Show forest plot

7

Mean Difference (IV, Fixed, 95% CI)

Totals not selected

Analysis 1.5

Comparison 1 Mediterranean dietary intervention versus no intervention or minimal intervention (secondary outcomes ‐ CVD risk factors), Outcome 5 HDL‐cholesterol (mmol/L), change from baseline.

Comparison 1 Mediterranean dietary intervention versus no intervention or minimal intervention (secondary outcomes ‐ CVD risk factors), Outcome 5 HDL‐cholesterol (mmol/L), change from baseline.

6 Triglycerides (mmol/L), change from baseline Show forest plot

6

Mean Difference (IV, Fixed, 95% CI)

Totals not selected

Analysis 1.6

Comparison 1 Mediterranean dietary intervention versus no intervention or minimal intervention (secondary outcomes ‐ CVD risk factors), Outcome 6 Triglycerides (mmol/L), change from baseline.

Comparison 1 Mediterranean dietary intervention versus no intervention or minimal intervention (secondary outcomes ‐ CVD risk factors), Outcome 6 Triglycerides (mmol/L), change from baseline.

7 Systolic blood pressure (mmHg), change from baseline Show forest plot

5

Mean Difference (IV, Fixed, 95% CI)

Totals not selected

Analysis 1.7

Comparison 1 Mediterranean dietary intervention versus no intervention or minimal intervention (secondary outcomes ‐ CVD risk factors), Outcome 7 Systolic blood pressure (mmHg), change from baseline.

Comparison 1 Mediterranean dietary intervention versus no intervention or minimal intervention (secondary outcomes ‐ CVD risk factors), Outcome 7 Systolic blood pressure (mmHg), change from baseline.

8 Diastolic blood pressure (mmHg), change from baseline Show forest plot

5

Mean Difference (IV, Fixed, 95% CI)

Totals not selected

Analysis 1.8

Comparison 1 Mediterranean dietary intervention versus no intervention or minimal intervention (secondary outcomes ‐ CVD risk factors), Outcome 8 Diastolic blood pressure (mmHg), change from baseline.

Comparison 1 Mediterranean dietary intervention versus no intervention or minimal intervention (secondary outcomes ‐ CVD risk factors), Outcome 8 Diastolic blood pressure (mmHg), change from baseline.

Study flow diagram.
Figuras y tablas -
Figure 1

Study flow diagram.

Comparison 1 Mediterranean dietary intervention versus no intervention or minimal intervention (secondary outcomes ‐ CVD risk factors), Outcome 1 Total cholesterol (mmol/L), change from baseline.
Figuras y tablas -
Analysis 1.1

Comparison 1 Mediterranean dietary intervention versus no intervention or minimal intervention (secondary outcomes ‐ CVD risk factors), Outcome 1 Total cholesterol (mmol/L), change from baseline.

Comparison 1 Mediterranean dietary intervention versus no intervention or minimal intervention (secondary outcomes ‐ CVD risk factors), Outcome 2 Total cholesterol (mmol/L), change from baseline, subgroup analysis.
Figuras y tablas -
Analysis 1.2

Comparison 1 Mediterranean dietary intervention versus no intervention or minimal intervention (secondary outcomes ‐ CVD risk factors), Outcome 2 Total cholesterol (mmol/L), change from baseline, subgroup analysis.

Comparison 1 Mediterranean dietary intervention versus no intervention or minimal intervention (secondary outcomes ‐ CVD risk factors), Outcome 3 LDL‐cholesterol (mmol/L), change from baseline.
Figuras y tablas -
Analysis 1.3

Comparison 1 Mediterranean dietary intervention versus no intervention or minimal intervention (secondary outcomes ‐ CVD risk factors), Outcome 3 LDL‐cholesterol (mmol/L), change from baseline.

Comparison 1 Mediterranean dietary intervention versus no intervention or minimal intervention (secondary outcomes ‐ CVD risk factors), Outcome 4 LDL‐cholesterol (mmol/L), change from baseline, subgroup analysis.
Figuras y tablas -
Analysis 1.4

Comparison 1 Mediterranean dietary intervention versus no intervention or minimal intervention (secondary outcomes ‐ CVD risk factors), Outcome 4 LDL‐cholesterol (mmol/L), change from baseline, subgroup analysis.

Comparison 1 Mediterranean dietary intervention versus no intervention or minimal intervention (secondary outcomes ‐ CVD risk factors), Outcome 5 HDL‐cholesterol (mmol/L), change from baseline.
Figuras y tablas -
Analysis 1.5

Comparison 1 Mediterranean dietary intervention versus no intervention or minimal intervention (secondary outcomes ‐ CVD risk factors), Outcome 5 HDL‐cholesterol (mmol/L), change from baseline.

Comparison 1 Mediterranean dietary intervention versus no intervention or minimal intervention (secondary outcomes ‐ CVD risk factors), Outcome 6 Triglycerides (mmol/L), change from baseline.
Figuras y tablas -
Analysis 1.6

Comparison 1 Mediterranean dietary intervention versus no intervention or minimal intervention (secondary outcomes ‐ CVD risk factors), Outcome 6 Triglycerides (mmol/L), change from baseline.

Comparison 1 Mediterranean dietary intervention versus no intervention or minimal intervention (secondary outcomes ‐ CVD risk factors), Outcome 7 Systolic blood pressure (mmHg), change from baseline.
Figuras y tablas -
Analysis 1.7

Comparison 1 Mediterranean dietary intervention versus no intervention or minimal intervention (secondary outcomes ‐ CVD risk factors), Outcome 7 Systolic blood pressure (mmHg), change from baseline.

Comparison 1 Mediterranean dietary intervention versus no intervention or minimal intervention (secondary outcomes ‐ CVD risk factors), Outcome 8 Diastolic blood pressure (mmHg), change from baseline.
Figuras y tablas -
Analysis 1.8

Comparison 1 Mediterranean dietary intervention versus no intervention or minimal intervention (secondary outcomes ‐ CVD risk factors), Outcome 8 Diastolic blood pressure (mmHg), change from baseline.

Comparison 1. Mediterranean dietary intervention versus no intervention or minimal intervention (secondary outcomes ‐ CVD risk factors)

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Total cholesterol (mmol/L), change from baseline Show forest plot

8

4151

Mean Difference (IV, Random, 95% CI)

‐0.16 [‐0.26, ‐0.06]

2 Total cholesterol (mmol/L), change from baseline, subgroup analysis Show forest plot

8

3815

Mean Difference (IV, Fixed, 95% CI)

‐0.20 [‐0.23, ‐0.17]

2.1 Interventions described as Mediterranean diet (or comprise both increased fruit and vegetables and monounsaturated fatty acids)

4

436

Mean Difference (IV, Fixed, 95% CI)

‐0.23 [‐0.27, ‐0.20]

2.2 Interventions with 2 components but not described as Mediterranean diet or comprising both increased fruit and vegetables and monounsaturated fatty acids

4

3379

Mean Difference (IV, Fixed, 95% CI)

‐0.06 [‐0.13, 0.01]

3 LDL‐cholesterol (mmol/L), change from baseline Show forest plot

6

3227

Mean Difference (IV, Fixed, 95% CI)

‐0.07 [‐0.13, ‐0.01]

4 LDL‐cholesterol (mmol/L), change from baseline, subgroup analysis Show forest plot

6

3227

Mean Difference (IV, Random, 95% CI)

‐0.07 [‐0.17, 0.03]

4.1 Interventions described as Mediterranean diet (or comprise both increased fruit and vegetables and monounsaturated fatty acids)

3

252

Mean Difference (IV, Random, 95% CI)

‐0.16 [‐0.39, 0.07]

4.2 Interventions with 2 components but not described as the Mediterranean diet or comprising both increased F&V and MUFAs

3

2975

Mean Difference (IV, Random, 95% CI)

‐0.06 [‐0.12, 0.00]

5 HDL‐cholesterol (mmol/L), change from baseline Show forest plot

7

Mean Difference (IV, Fixed, 95% CI)

Totals not selected

6 Triglycerides (mmol/L), change from baseline Show forest plot

6

Mean Difference (IV, Fixed, 95% CI)

Totals not selected

7 Systolic blood pressure (mmHg), change from baseline Show forest plot

5

Mean Difference (IV, Fixed, 95% CI)

Totals not selected

8 Diastolic blood pressure (mmHg), change from baseline Show forest plot

5

Mean Difference (IV, Fixed, 95% CI)

Totals not selected

Figuras y tablas -
Comparison 1. Mediterranean dietary intervention versus no intervention or minimal intervention (secondary outcomes ‐ CVD risk factors)